Bayer (BAYRY.PK -0.8%) and Onyx Pharmaceuticals (ONXX -0.2%) say they've submitted a New Drug...

|About: Bayer A.G. ADR (BAYRY)|By:, SA News Editor

Bayer (BAYRY.PK -0.8%) and Onyx Pharmaceuticals (ONXX -0.2%) say they've submitted a New Drug Application to the FDA for their oral multi-kinase inhibitor regorafenib for the treatment of gastrointestinal tumors in patients whose disease has progressed despite prior treatment. Both companies will jointly promote the drug in the United States, while ONXX will receive a royalty on any future global net sales.